NCT01218243
- Conditions
- Benign Prostatic Hyperplasia (BPH), Genital Diseases, Genital Diseases, Male, +14 more
- Locations
-
- Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences Beijing, China
Clinical trial condition
Benign Prostatic Hyperplasia (BPH)
Explore clinical trials studying Benign Prostatic Hyperplasia (BPH). Study availability and eligibility vary by location and protocol.
49 public trials
7 recruiting studies
Benign Prostatic Hyperplasia (BPH) trial results
NCT01829893
- Conditions
- Benign Prostatic Hyperplasia (BPH), Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- Clinical trial center of Anam Hospital Seoul, South Korea
NCT00700505
- Conditions
- Benign Prostatic Hyperplasia (BPH), Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
- Locations
-
- Mobley Clinical Research Center Houston, Texas, United States
Completed
Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)
NCT00759135
- Conditions
- Benign Prostatic Hyperplasia (BPH), Enlarged Prostate, Genital Diseases, +5 more
- Locations
-
- Nymox Investigational Site Huntsville, Alabama, United States
- Nymox Investigational Site Tucson, Arizona, United States
- Nymox Investigational Site Little Rock, Arkansas, United States
- Nymox Investigational Site Anaheim, California, United States
NCT01566292
- Conditions
- Benign Prostatic Enlargement (BPE), Benign Prostatic Hyperplasia (BPH), Genital Diseases, +5 more
- Locations
-
- Catholic University of Sacred Heart Rome, Italy
NCT00970632
- Conditions
- Benign Prostatic Hyperplasia (BPH), Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Adelaide, South Australia, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bentleigh East, Victoria, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bunbury, Western Australia, Australia
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nedlands, Western Australia, Australia
NCT00224107
- Conditions
- Benign Prostatic Hyperplasia (BPH), Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- Huntsville, Alabama, United States
- Tucson, Arizona, United States
- Anaheim, California, United States
- Culver City, California, United States
NCT01222650
- Conditions
- Benign Prostatic Hyperplasia (BPH), Genital Diseases, Genital Diseases, Male, +4 more
- Locations
-
- Japan Kanto Region, Japan
Active, Not Recruiting
REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active Men
NCT04838769
- Conditions
- Benign Prostatic Hyperplasia (BPH), Genital Diseases, Genital Diseases, Male, +8 more
- Locations
-
- Epworth Healthcare Melbourne, Australia
- Australian Clinical Trials Wahroonga, Australia
- Centre Hospitalier du Pays d'Aix Aix-en-Provence, France
- CHU d'Angers Angers, France